08/21/2025 3:56 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2025 8:31 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2025 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
08/18/2025 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
08/08/2025 3:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
08/01/2025 8:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2025 8:21 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2025 8:15 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2025 8:10 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025 8:25 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2025 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for NRSN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
04/16/2025 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/11/2025 3:00 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
04/11/2025 3:00 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
04/07/2025 4:25 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 7:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2025 7:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2025 8:13 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
01/06/2025 9:40 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2024 3:47 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
12/23/2024 8:04 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2024 10:06 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 1:42 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
12/12/2024 4:08 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/04/2024 7:32 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024 3:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/24/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
11/22/2024 3:30 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
10/31/2024 3:59 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 8:45 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 7:35 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024 7:30 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 8:35 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024 8:13 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
10/01/2024 5:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
09/30/2024 3:53 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024 8:25 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 5:10 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad) Right now, we’re witnessing a monumental shift in the world. Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. |
09/09/2024 5:10 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024 4:00 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/28/2024 6:05 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |